Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bonnel

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Toxicologic Pathology|June 24, 2017
Regulatory Forum Opinion Piece*: Imaging Applications in Toxicologic Pathology-Recommendations for Use in Regulated Nonclinical Toxicity StudiesRobert R Maronpot, Abraham Nyska, Sean P Troth, et al.
Therapie|January 22, 2026
Pharmaco-metabolomics and metabolomics: A new tool in precision medicine?Antonin Lamazière, Erwan Werner, Caroline Barau, et al.
Therapie|January 28, 2026
Antonin Lamazière, Erwan Werner, Caroline Barau, et al.
Cancers|March 25, 2022
Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled TrialSelinde S Wind, Manon A A Jansen, Melanie Rijsbergen, et al.
Cancers|March 11, 2023
Correction: Wind et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. <i>Cancers</i> 2022, <i>14</i>, 1510Selinde S Wind, Manon A A Jansen, Melanie Rijsbergen, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Toxicologic Pathology|June 24, 2017
Regulatory Forum Opinion Piece*: Imaging Applications in Toxicologic Pathology-Recommendations for Use in Regulated Nonclinical Toxicity StudiesRobert R Maronpot, Abraham Nyska, Sean P Troth, et al.
Therapie|January 22, 2026
Pharmaco-metabolomics and metabolomics: A new tool in precision medicine?Antonin Lamazière, Erwan Werner, Caroline Barau, et al.
Therapie|January 28, 2026
Antonin Lamazière, Erwan Werner, Caroline Barau, et al.
Cancers|March 25, 2022
Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled TrialSelinde S Wind, Manon A A Jansen, Melanie Rijsbergen, et al.
Cancers|March 11, 2023
Correction: Wind et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. <i>Cancers</i> 2022, <i>14</i>, 1510Selinde S Wind, Manon A A Jansen, Melanie Rijsbergen, et al.
Pageof 3